Equities

Goodrx Holdings Inc

GDRX:NSQ

Goodrx Holdings Inc

Actions
  • Price (USD)39.66
  • Today's Change1.59 / 4.18%
  • Shares traded1.45m
  • 1 Year change+7.77%
  • Beta--
Data delayed at least 15 minutes, as of Dec 02 2021 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources. Its platform also provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharmaceutical manufacturer solutions offering provides advertising and integrated consumer affordability solutions to pharmaceutical manufacturers.

  • Revenue in USD (TTM)685.71m
  • Net income in USD-283.61m
  • Incorporated--
  • Employees--
  • Location
    Goodrx Holdings Inc2701 Olympic Boulevard, Suite 990SANTA MONICA 90404United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://investors.goodrx.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GDRX:NSQ since
announced
Transaction
value
RxSaver IncDeal completed30 Apr 202130 Apr 2021Deal completed-2.03%50.00m
Data delayed at least 15 minutes, as of Dec 02 2021 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tusimple Holdings Inc-100.00bn-100.00bn7.97bn1.00k--5.65----------6.62----------------------------0.0033--159.58---37.08------
Dun & Bradstreet Holdings Inc2.05bn-53.80m8.02bn4.04k--2.2414.753.92-0.1067-0.1055.518.310.2163--7.60506,907.70-0.5356---0.5927--69.27---2.48----1.080.4949--9.14--68.86------
Concentrix Corp5.42bn342.10m8.62bn270.00k25.023.3013.731.596.586.58104.3649.961.07--5.1720,078.766.83--10.53--35.21--6.38----19.980.2523--0.2469--40.67------
GDS Holdings Ltd - ADR1.14bn-197.48m10.63bn1.48k--2.5758.539.32-1.10-1.106.3621.660.1344--4.22771,235.10-2.13-2.04-2.50-2.4123.7125.38-15.83-14.00--0.3680.5324--39.2152.16-47.49--62.16--
Tencent Music Entertainment Group - ADR5.02bn579.52m11.27bn4.77k19.391.44--2.240.34350.34352.984.640.4901848.5813.191,052,900.005.90--6.93--30.99--12.04--2.62--0.0972--14.62--4.34------
IAC/Interactivecorp3.39bn1.08bn11.50bn8.20k10.561.589.453.3912.1612.1437.5281.220.3785--12.32413,293.2012.183.4814.334.4868.9777.4832.186.77----0.05960.0012.64-1.161,078.1017.69-0.1549--
Doximity Inc-100.00bn-100.00bn12.14bn713.00--15.67----------4.13----------------------------0.00--77.76--99.06------
Leidos Holdings Inc13.50bn776.00m12.27bn39.00k16.182.9811.240.90935.415.4194.0629.391.0641.086.49346,102.606.105.378.327.0614.7913.565.784.670.98637.190.550438.8710.8421.15-5.8520.9146.631.22
LYFT Inc2.81bn-1.21bn13.02bn4.68k--8.77--4.64-3.71-3.718.534.360.5736----600,699.40-24.69---45.22--32.93---43.05-----34.350.3338---34.60--32.64------
Goodrx Holdings Inc685.71m-283.61m15.19bn----17.93--22.15-0.7178-0.71781.652.120.4338--8.46---17.94---18.73--93.88---41.36-----12.080.4396--41.85---544.56------
FactSet Research Systems Inc.1.59bn399.59m17.42bn10.89k44.6717.1337.5410.9510.3610.3641.2627.020.7388--10.39146,111.5018.5520.6621.5024.0950.5959.1525.1123.59--76.670.361130.676.517.147.153.355.1411.08
Broadridge Financial Solutions, Inc.5.17bn548.90m19.61bn13.70k36.1911.1722.323.794.654.6543.7915.070.8091--7.66377,203.808.5910.929.9214.0828.4627.3310.6210.12--10.660.703747.0210.2611.5118.3812.235.9313.90
TransUnion3.01bn471.40m20.96bn8.20k44.737.2824.116.962.452.4515.6215.040.4093--6.12367,048.806.614.737.375.2466.5566.3716.1612.48--10.560.527611.532.2812.51-2.36125.3910.12--
Data as of Dec 02 2021. Currency figures normalised to Goodrx Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

45.65%Per cent of shares held by top holders
HolderShares% Held
Abdiel Capital Advisors LPas of 30 Sep 20218.79m11.66%
The Vanguard Group, Inc.as of 30 Sep 20215.49m7.28%
Wellington Management Co. LLPas of 30 Sep 20215.25m6.96%
Morgan Stanley Investment Management, Inc.as of 30 Sep 20213.21m4.26%
Tiger Global Management LLCas of 30 Sep 20212.35m3.11%
Atreides Management LPas of 30 Sep 20212.31m3.07%
Light Street Capital Management LLCas of 30 Sep 20212.02m2.67%
Fidelity Management & Research Co. LLCas of 30 Sep 20211.89m2.50%
Carmignac Gestion SAas of 30 Sep 20211.78m2.36%
Zevenbergen Capital Investments LLCas of 30 Sep 20211.34m1.78%
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.